The non-covid dividends from Test and Trace

Axel Heitmueller

The UK’s covid testing work offers several promising — and dramatic — longer term dividends for public health and healthcare, says Axel Heitmueller, who oversaw developments at NHS Test and Trace.

Register with to read the rest of this article


Critical stories remain free for registered users

Certain articles and Insight pieces remain paying-subscriber only content

As a registered user you will get access to:

  • Daily News: an essential email round-up of all the latest news, comment and best practice
  • Breaking news headlines delivered directly to your inbox
  • Limited access to

Already registered to HSJ? Sign in now